
Jana A. Hines
Examiner (ID: 16557, Phone: (571)272-0859 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1641 |
| Total Applications | 1211 |
| Issued Applications | 526 |
| Pending Applications | 177 |
| Abandoned Applications | 527 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14233427
[patent_doc_number] => 20190128886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/095777
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095777 | ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS | Apr 26, 2017 | Abandoned |
Array
(
[id] => 11853043
[patent_doc_number] => 20170227535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'ANALYZING BACTERIA WITHOUT CULTURING'
[patent_app_type] => utility
[patent_app_number] => 15/496790
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9226
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496790
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496790 | Analyzing bacteria without culturing | Apr 24, 2017 | Issued |
Array
(
[id] => 14273785
[patent_doc_number] => 20190134177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => CONJUGATE FOR VACCINATION AGAINST TYPHOID COMPRISING CHEMICAL CONJUGATE OF VI POLYSACCHARIDE AND FLAGELLIN, A PROCESS FOR PRODUCING THE SAME AND A COMPOSITION COMPRISING THE CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 16/096387
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096387 | CONJUGATE FOR VACCINATION AGAINST TYPHOID COMPRISING CHEMICAL CONJUGATE OF VI POLYSACCHARIDE AND FLAGELLIN, A PROCESS FOR PRODUCING THE SAME AND A COMPOSITION COMPRISING THE CONJUGATE | Apr 20, 2017 | Abandoned |
Array
(
[id] => 12003435
[patent_doc_number] => 20170307590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'INHIBITORS OF MALARIAL AND HUMAN GLUCOSE TRANSPORTERS AND METHODS FOR IDENTIFYING THE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/492550
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492550 | INHIBITORS OF MALARIAL AND HUMAN GLUCOSE TRANSPORTERS AND METHODS FOR IDENTIFYING THE INHIBITORS | Apr 19, 2017 | Abandoned |
Array
(
[id] => 14960791
[patent_doc_number] => 20190307873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => NOVEL PNEUMOCOCCAL VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/091032
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091032
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091032 | Pneumococcal vaccine formulations | Apr 4, 2017 | Issued |
Array
(
[id] => 11977603
[patent_doc_number] => 20170281757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'PROBIOTICS, SECRETORY IgA AND INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/468961
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4899
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468961 | PROBIOTICS, SECRETORY IgA AND INFECTION | Mar 23, 2017 | Abandoned |
Array
(
[id] => 18028945
[patent_doc_number] => 11512118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Treatment of microbial infections
[patent_app_type] => utility
[patent_app_number] => 15/463665
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14806
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463665 | Treatment of microbial infections | Mar 19, 2017 | Issued |
Array
(
[id] => 12002166
[patent_doc_number] => 20170306321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'SYSTEMS AND METHODS FOR GENETIC ANALYSIS OF INTRACTABLE MICROBES'
[patent_app_type] => utility
[patent_app_number] => 15/462749
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10265
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462749
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462749 | Systems and methods for genetic analysis of intractable microbes | Mar 16, 2017 | Issued |
Array
(
[id] => 14171739
[patent_doc_number] => 10259865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
[patent_app_type] => utility
[patent_app_number] => 15/460147
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 21
[patent_no_of_words] => 23650
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/460147 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | Mar 14, 2017 | Issued |
Array
(
[id] => 18084376
[patent_doc_number] => 11534483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Compositions for the treatment and prevention of hoof and claw diseases
[patent_app_type] => utility
[patent_app_number] => 16/085025
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24942
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085025 | Compositions for the treatment and prevention of hoof and claw diseases | Mar 14, 2017 | Issued |
Array
(
[id] => 11948269
[patent_doc_number] => 20170252419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Genetic Attenuation of Plasmodium by B9 Gene Disruption'
[patent_app_type] => utility
[patent_app_number] => 15/458849
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 25617
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458849 | Genetic attenuation of plasmodium by B9 gene disruption | Mar 13, 2017 | Issued |
Array
(
[id] => 11704664
[patent_doc_number] => 20170173163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'CONJUGATE OF A FRAGMENT OF A CELLULAR WALL OF A BACTERIUM AND A MUCOPOLYSACCHARIDIC CARRIER, AND USES IN MEDICINE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/446824
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8209
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446824 | Conjugate of a fragment of a cellular wall of a bacterium and a mucopolysaccharidic carrier, and uses in medicine thereof | Feb 28, 2017 | Issued |
Array
(
[id] => 11942073
[patent_doc_number] => 20170246224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'DIRECT-FED MICROBIALS'
[patent_app_type] => utility
[patent_app_number] => 15/445193
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17211
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/445193 | Direct-fed microbials | Feb 27, 2017 | Issued |
Array
(
[id] => 11942071
[patent_doc_number] => 20170246223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Combination Therapy for Solid Tumour Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/442043
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8400
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15442043
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/442043 | Combination Therapy for Solid Tumour Cancer | Feb 23, 2017 | Abandoned |
Array
(
[id] => 15345243
[patent_doc_number] => 20200010513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => LIGHT-GATED SIGNALING MODULATION
[patent_app_type] => utility
[patent_app_number] => 16/079773
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079773 | Light-gated signaling modulation | Feb 22, 2017 | Issued |
Array
(
[id] => 11589908
[patent_doc_number] => 20170114319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'ATTENUATED AND ADAPTED STRAIN OF PSEUDOMONAS FOR DELIVERING ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/397175
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6141
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397175 | ATTENUATED AND ADAPTED STRAIN OF PSEUDOMONAS FOR DELIVERING ANTIGENS | Jan 2, 2017 | Abandoned |
Array
(
[id] => 12051485
[patent_doc_number] => 20170327830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/392024
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27462
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392024 | ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF | Dec 27, 2016 | Abandoned |
Array
(
[id] => 13774823
[patent_doc_number] => 20190000950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COCCIDIOSIS VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/064027
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064027 | COCCIDIOSIS VACCINE | Dec 22, 2016 | Abandoned |
Array
(
[id] => 13824021
[patent_doc_number] => 20190015495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE
[patent_app_type] => utility
[patent_app_number] => 16/068409
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068409 | Vaccine strains of brachyspira hyodysenteriae | Dec 21, 2016 | Issued |
Array
(
[id] => 11704639
[patent_doc_number] => 20170173138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'IMMUNE HEALTH FOR COMPANION ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/372880
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6655
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372880 | IMMUNE HEALTH FOR COMPANION ANIMALS | Dec 7, 2016 | Abandoned |